or Try an Advanced Search...

    Technical Analysis for IMAB - I-Mab

    Grade Last Price % Change Price Change
    C 1.81 1.17% 0.02
    IMAB closed down 1.65 percent on Wednesday, May 8, 2024, on 38 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    Earnings due: May 29
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Flat Up
    Historical IMAB trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 1.17%
    Fell Below 50 DMA Bearish 1.17%
    Bollinger Band Squeeze Range Contraction 1.17%
    BB Squeeze + Upper Band Touch Range Contraction 1.17%
    Inside Day Range Contraction 1.17%
    Upper Bollinger Band Touch Strength 1.17%
    Crossed Above 20 DMA Bullish -0.49%
    Crossed Above 50 DMA Bullish -0.49%
    MACD Bullish Signal Line Cross Bullish -0.49%
    Pocket Pivot Bullish Swing Setup -0.49%
    Older End-of-Day Signals for IMAB ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 5 hours ago
    Rose Above Upper Bollinger Band about 5 hours ago
    Up 2% about 5 hours ago
    Upper Bollinger Band Resistance about 5 hours ago
    Rose Above 50 DMA about 5 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IMAB Chart by TradingView
    Basic chart:

    Profile

    I-Mab is a clinical stage biopharmaceutical company. It engages in discovering, developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pharmacy Medication Autoimmune Disorders Immune Disorders

    Is IMAB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 (IMAB) - Analyzing I-MAB's Short Interest
    May 2 Q1 2024 Summit Therapeutics Inc Earnings Call
    Apr 30 I-MAB Filed 2023 Annual Report on Form 20-F
    Apr 5 I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
    Apr 2 I-Mab Announces Closing of the Divestiture of Business Operations in China
    Mar 18 I-Mab Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
    Mar 14 I-Mab Biopharma GAAP EPS of -$1.01 beats by $0.76
    Mar 14 I-Mab Reports Full Year 2023 Financial Results and Business Update
    Feb 21 Q4 2023 Summit Therapeutics Inc Earnings Call
    Feb 18 I-Mab: Trading Below Net Cash With Multiple Upside Options
    See more IMAB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.45
    52 Week Low 1.16
    Average Volume 255,369
    200-Day Moving Average 1.76
    50-Day Moving Average 1.81
    20-Day Moving Average 1.80
    10-Day Moving Average 1.79
    Average True Range 0.07
    RSI (14) 48.45
    ADX 11.49
    +DI 22.14
    -DI 12.23
    Chandelier Exit (Long, 3 ATRs) 1.70
    Chandelier Exit (Short, 3 ATRs) 1.93
    Upper Bollinger Bands 1.83
    Lower Bollinger Band 1.76
    Percent B (%b) 0.43
    BandWidth 3.74
    MACD Line -0.01
    MACD Signal Line -0.01
    MACD Histogram 0.0003
    Fundamentals Value
    Market Cap 147.9 Million
    Num Shares 82.6 Million
    EPS -3.78
    Price-to-Earnings (P/E) Ratio -0.47
    Price-to-Sales 2.55
    Price-to-Book 0.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.91
    Resistance 3 (R3) 1.92 1.89 1.89
    Resistance 2 (R2) 1.89 1.86 1.88 1.88
    Resistance 1 (R1) 1.84 1.84 1.82 1.83 1.88
    Pivot Point 1.81 1.81 1.80 1.80 1.81
    Support 1 (S1) 1.76 1.78 1.75 1.75 1.70
    Support 2 (S2) 1.73 1.76 1.73 1.70
    Support 3 (S3) 1.68 1.73 1.69
    Support 4 (S4) 1.67